Document is current
Any future updates will be listed below
-
Authors
Milicic, Lidija
Vacher, Michael
Bourgeat, Pierrick
Doré, Vincent
Shishegar, Rosita
Maruff, Paul
Masters, Colin L.
Rowe, Christopher C.
Villemagne, Victor L.
Porter, Tenielle
Laws, Simon M.
,
,
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council (GNT1161706; GNT1191535; GNT1151854)
- License Information
-
More Information
Article History
Received: 21 July 2026
Accepted: 28 July 2026
First Online: 3 August 2026
Declarations
Competing interests: V.L.V. is and has been a consultant or paid speaker at sponsored conference sessions for Eli Lilly, Life Molecular Imaging, ACE Barcelona, and IXICO. P.M. is a full‐time employee of Cogstate Ltd. C.C.R. has served on scientific advisory boards for Bayer Pharma, Elan Corporation, GE Healthcare, and AstraZeneca; has received speaker honoraria from Bayer Pharma and GE Healthcare; and has received research support from Bayer Pharma, GE Healthcare, Piramal Lifesciences, and Avid Radiopharmaceuticals. L.M., M.V. V.D., P.B., R.S., J.D.D., T.P., S.M.L. report no relevant disclosures.
Ethical approval and consent to participate: Informed written consent was given by all volunteers and ethics approvals have been granted by the institutional ethics committees of Austin Health, St. Vincent’s Health, Hollywood Private Hospital and Edith Cowan University for the AIBL study. The institutional review boards of all participating ADNI sites reviewed and approved the data collection protocols provided by ADNI. Both AIBL and ADNI studies were carried out in accordance with the guidelines of the Declaration of Helsinki.
